Pyeloplasty In Pediatric Population Research Articles

Minimally invasive versus open pyeloplasty in pediatric population: Comparative retrospective study in tertiary centre.

Ureteropelvic junction obstruction (UPJO) is the most common cause of antenatal hydronephrosis. The incidence is around 1: 750-1500 live births. The standard treatment for (UPJO) is open pyeloplasty (OP) with a high success rate of 90%-95%. In the last 20 years, minimal invasive pyeloplasty (MIP) became an excellent alternative technique to OP which was historically the standard of care. The study participants were male and female patients aged 14 years old or less who had undergone open/minimally invasive pyeloplasty during 2015-2020 and who had at least 1-year follow-up after surgery. The data were collected retrospectively from patients' charts. The patients were categorized into two cohort groups: OP and on the other arm minimally invasive pyeloplasty (robotic/laparoscopic) comparing the outcomes as a 1ry endpoint. 2ry endpoints were hospital stay, duration of surgery, and anteroposterior diameter of renal ultrasound. A total of 133 patients were included in the study. Eighty-four underwent MIP while 49 patients underwent OP. 1ry endpoint was the success rate in both groups. The success rate was 94% (n: 79) and 98% (n: 48) in patients who underwent MIP and OP, respectively. P <0.05 is considered significant. Open and minimally invasive pyeloplasty are comparable in terms of success rate. However, OP was associated with shorter hospital stays and shorter operative times.

A comparative study of pyeloplasty in children with and without stenting

Background: PUJ obstruction is the most common among the major obstructive pathologies in pediatric patients. The study aims to compare the benefits and drawbacks of stentless pyeloplasty in pediatric population with routine DJ stent insertion.Methods: Data was collected for operated cases of PUJ obstruction and categorised into those who had DJ stent in situ and those without DJ stent. Complications associated with both these approaches was systematically assessed.Results: In patients with DJ stent in situ the perinephric drain was minimal and hence most of the patients had their drain removed on the 2nd or 3rd day. In those patients without DJ stent in situ, the average duration for removal of drain was prolonged to about 7 days.Conclusions: Routine use of Ureteric stenting with DJ stent in this series of patients was associated with decreased hospital stay and morbidity in patients without DJ stent.